company background image
1BAYN logo

Bayer BIT:1BAYN Stock Report

Last Price

€28.34

Market Cap

€27.9b

7D

7.3%

1Y

-51.1%

Updated

28 Mar, 2024

Data

Company Financials +

Bayer Aktiengesellschaft

BIT:1BAYN Stock Report

Market Cap: €27.9b

1BAYN Stock Overview

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide.

1BAYN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Bayer Aktiengesellschaft Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bayer
Historical stock prices
Current Share Price€28.34
52 Week High€61.74
52 Week Low€24.97
Beta0.97
1 Month Change-2.63%
3 Month Change-16.79%
1 Year Change-51.06%
3 Year Change-46.89%
5 Year Change-53.37%
Change since IPO103.99%

Recent News & Updates

Recent updates

Shareholder Returns

1BAYNIT PharmaceuticalsIT Market
7D7.3%0.7%1.3%
1Y-51.1%12.3%25.2%

Return vs Industry: 1BAYN underperformed the Italian Pharmaceuticals industry which returned 12.3% over the past year.

Return vs Market: 1BAYN underperformed the Italian Market which returned 25.2% over the past year.

Price Volatility

Is 1BAYN's price volatile compared to industry and market?
1BAYN volatility
1BAYN Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement4.2%
10% most volatile stocks in IT Market7.8%
10% least volatile stocks in IT Market2.6%

Stable Share Price: 1BAYN's share price has been volatile over the past 3 months.

Volatility Over Time: 1BAYN's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
186396,931Bill Andersonhttps://www.bayer.com

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Bayer Aktiengesellschaft Fundamentals Summary

How do Bayer's earnings and revenue compare to its market cap?
1BAYN fundamental statistics
Market cap€27.93b
Earnings (TTM)-€2.94b
Revenue (TTM)€47.64b

0.6x

P/S Ratio

-9.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1BAYN income statement (TTM)
Revenue€47.64b
Cost of Revenue€19.75b
Gross Profit€27.89b
Other Expenses€30.83b
Earnings-€2.94b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 14, 2024

Earnings per share (EPS)-2.99
Gross Margin58.55%
Net Profit Margin-6.17%
Debt/Equity Ratio132.3%

How did 1BAYN perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

-4%

Payout Ratio

Does 1BAYN pay a reliable dividends?

See 1BAYN dividend history and benchmarks
When do you need to buy 1BAYN by to receive an upcoming dividend?
Bayer dividend dates
Ex Dividend DateApr 29 2024
Dividend Pay DateMay 02 2024
Days until Ex dividend31 days
Days until Dividend pay date34 days

Does 1BAYN pay a reliable dividends?

See 1BAYN dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.